PRM Stock Overview
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Big Pharma Split Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$13.40 |
| 52 Week High | CA$16.04 |
| 52 Week Low | CA$13.20 |
| Beta | 0.88 |
| 1 Month Change | -6.62% |
| 3 Month Change | -7.27% |
| 1 Year Change | -14.60% |
| 3 Year Change | -2.55% |
| 5 Year Change | 11.39% |
| Change since IPO | -7.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| PRM | CA Capital Markets | CA Market | |
|---|---|---|---|
| 7D | -3.3% | -1.8% | -1.4% |
| 1Y | -14.6% | 22.3% | 4.7% |
Return vs Industry: PRM underperformed the Canadian Capital Markets industry which returned 22.9% over the past year.
Return vs Market: PRM underperformed the Canadian Market which returned 5.8% over the past year.
Price Volatility
| PRM volatility | |
|---|---|
| PRM Average Weekly Movement | 2.4% |
| Capital Markets Industry Average Movement | 4.5% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.6% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: PRM has not had significant price volatility in the past 3 months.
Volatility Over Time: PRM's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | n/a | www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/ |
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Big Pharma Split Corp. Fundamentals Summary
| PRM fundamental statistics | |
|---|---|
| Market cap | CA$15.88m |
| Earnings (TTM) | -CA$645.35k |
| Revenue (TTM) | CA$320.82k |
48.6x
P/S Ratio-24.2x
P/E RatioIs PRM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRM income statement (TTM) | |
|---|---|
| Revenue | CA$320.82k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$320.82k |
| Other Expenses | CA$966.17k |
| Earnings | -CA$645.35k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.55 |
| Gross Margin | 100.00% |
| Net Profit Margin | -201.16% |
| Debt/Equity Ratio | 65.0% |
How did PRM perform over the long term?
See historical performance and comparison